Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results is a research paper published in Clinical Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL141505
NIAMS NIH HHS
Grant: R01 AR080194
NIA NIH HHS
Grant: R01 AG053302
NIA NIH HHS
Grant: R01 AG060163
NIA NIH HHS
Grant: K24 AG073527
Fields of Study
MeSH Terms